ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N01AH06 | G | Remifentanil (HCl) - 5mg | 8101 | 186198/13 | REMIFENTANIL MEDIS | 5mg | 5 | Injectable powder | Infusion/IV | Medis Pharm Drugstore | Les Laboratoires Medis SA | Tunisia | 2,576,146 L.L | 23.08 | B | Les Laboratoires Medis SA | Tunisia | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N01AH06 | B | Remifentanil (HCl) - 5mg | 9423 | 29018/1 | ULTIVA | 5mg | 5 | Injectable powder for solution | Infusion/IV | Abela Frères S.A.L. | GlaxoSmithKline Manufacturing SpA | Italy | 3,119,058 L.L | 23.08 | B | Aspen Pharma Trading Limited | Ireland | 2/5/2024 | 0 |